echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > China Council for the promotion of drugs organized and held a symposium on enterprises with amendments to the measures for the administration of drug registration

    China Council for the promotion of drugs organized and held a symposium on enterprises with amendments to the measures for the administration of drug registration

    • Last Update: 2013-11-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: China Council for the promotion of drugs November 29, 2013 November 28, 2013 On the afternoon of November, the enterprise Symposium on the amendment to the measures for the administration of drug registration (hereinafter referred to as the "amendment") was successfully held in Beijing, organized by the China Council for the promotion of drugs, aiming at the public opinions of the drug and cosmetic registration department of the State Food and Drug Administration (hereinafter referred to as the "drug registration department") Song Ruilin, executive chairman of CFDA, presided over the meeting, and Li Jinju, director of the pharmaceutical registration department of the State Food and drug administration, attended the meeting The meeting was also attended by representatives of more than a dozen well-known pharmaceutical enterprises in China, including Tianshili holding group, China Pharmaceutical Group, Shanghai Fosun, Shiyao group, Jiangsu Hengrui, Zhejiang Kangenbei, Beida pharmaceutical, Kexin Bicheng, Shenzhen micro core, Yabao pharmaceutical, etc Chen Changxiong, Executive Deputy Secretary General of the China Council for the promotion of drugs, made a brief description of the main amendment points of the amendment, and the participants expressed their opinions on the contents of the amendment, launched intense discussions and exchanges, and achieved good results The amendment of this registration method involves 12 terms, including one deleted, one merged and four added The revised content involves drug innovation, drug patents, new drug monitoring period, and on-site inspection of generic drug registration and production closely related to the development of pharmaceutical enterprises Song Ruilin, executive chairman of the China Association for the promotion of drugs, pointed out that although there are some unsatisfactory aspects in this revision, it is not as simple as scratching the itch, but a substantial change has been made in response to the situation that the implementation of the measures for the administration of drug registration does not conform to the new situation and new requirements, simplifying the registration and approval procedures, and the general direction and trend of the future development of Chinese pharmaceutical enterprises Potential has a profound impact President Song hoped that member enterprises could form written opinions on the amendment, summarize the drug administration Promotion Association as soon as possible, and form a unified opinion and report it to the pharmaceutical registration department Director Li Jinju explained the original intention of the amendments, and accepted the opinions of the enterprises modestly, saying that the voice of the enterprises will be considered in the next step of improvement Song Ruilin, executive chairman of CFDA, presided over the meeting, and Li Jinju, director of research and supervision department of CFDA drug and cosmetics registration administration, delivered a speech at the meeting site
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.